Lupin to market Novartis' inhaler under Loftair brand name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India
Apr 11, 2016, 17:24 PM IST